Ginko Biloba Versus Desmopressin in Treatment of Children With Monosymptomatic Nocturnal Enuresis

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

July 1, 2024

Study Completion Date

December 1, 2024

Conditions

Enuresis, Nocturnal

Interventions

DRUG

Desmopressin Acetate 0.2 mg Tablets

3 groups of patients one received only desmopressin and group ginkobiloba ablnd group for both

DRUG

Ginkgobiloba

Group s take it as treatment of deep sleep in nectornal enuresis

Trial Locations (1)

Menofia university, Cairo

All Listed Sponsors

lead

Menoufia University

OTHER

NCT06772584 - Ginko Biloba Versus Desmopressin in Treatment of Children With Monosymptomatic Nocturnal Enuresis | Biotech Hunter | Biotech Hunter